MENS: Gunggung utang perusahaan Jyong Biotech

Simbol lan logo merek Jyong Biotech Limited (MENS)

Jyong Biotech Ltd focuses on creating botanical products for urology. Developing plant-based supplements for the global market helps diversify the portfolio and mitigate regional risks. The company's debt history on the GURU.Markets chart confirms the financial dynamics, where 0.00 reflects the latest metric value. However, reliance on government contracts and strict pricing control in China limit the business's margins.

MENS: Utang perusahaan Jyong Biotech Ltd 18.06.2025 - 30.10.2026
Produk mawa merek Jyong Biotech Limited

The development of plant-based pharmaceuticals and the diversification of sales markets for Jyong Biotech Ltd. (MENS) require precise capital management to scale expansion. Analyzing the overall debt burden, the investor assesses the balance between revenue stimulation and default risks, determining the company's ability to withstand a drop in demand without losing financial stability based on the dynamics of its liabilities.

Karo sapa Jyong Biotech Ltd saingan

HLN (Haleon Corp) - Kewajiban utang agregat|Gunggung utang perusahaan KVUE (Kenvue Inc.)|Gunggung utang perusahaan veronapharma.com VRNA|LGND - Utang perusahaan|Kewajiban utang agregat AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Utang perusahaan|Gunggung utang perusahaan Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Gunggung utang perusahaan|Gunggung utang perusahaan glpg.com|Gunggung utang perusahaan ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Kewajiban utang agregat|Utang perusahaan Amphastar AMPH|Pacira Corp (PCRX) - Utang kumulatif perusahaan|SPRY: Gunggung utang perusahaan|theravance.com - Tanggungan utang kumulatif perusahaan|AQST: Gunggung utang perusahaan|scPharmaceuticals - Kewajiban utang agregat|TECX (Tectonic Therapeutic Inc.) - Gunggung utang perusahaan|Utang kumulatif perusahaan Tonix Pharmaceuticals Holding TNXP|Utang perusahaan China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Kewajiban utang agregat|Utang perusahaan BioHarvest Sciences Inc. BHST|Tanggungan utang kumulatif perusahaan EXOZ (Invizyne Technologies)|ORMP: Gunggung utang perusahaan|Utang kumulatif perusahaan Entera Bio Ltd.|MindWalk Holdings (HYFT) - Utang perusahaan|Utang kumulatif perusahaan abvcpharma.com (ABVC)|Utang perusahaan Cumberland Pharmaceuticals Inc.|Utang agregat perusahaan QNTM (Quantum BioPharma Ltd.)|Gunggung utang perusahaan FGEN|Telomir Pharmaceuticals Corp (TELO) - Tanggungan utang total perusahaan|Rani Therapeutics Holdings, Inc. - Gunggung utang perusahaan|Kewajiban utang agregat SNYR|Rallybio Corp. - Gunggung utang perusahaan|LEXX: Utang perusahaan|PULM: Gunggung utang perusahaan|PTHL - Gunggung kewajiban utang perusahaan|Utang perusahaan Aptorum Group Ltd|Utang kumulatif perusahaan lyratherapeutics.com LYRA|Gunggung utang perusahaan IBO (Impact BioMedical)|Tanggungan utang kumulatif perusahaan TNFA|Gunggung utang perusahaan YCBD (cbdMD)|PainReform Corp (PRFX) - Utang kumulatif perusahaan|Auris Medical - Gunggung utang perusahaan|lipella.com (LIPO) - Gunggung utang perusahaan|OPTN: Gunggung utang perusahaan|Pieris Pharmaceuticals Inc - Kewajiban utang agregat|Gunggung utang perusahaan PROC|PTPI: Kewajiban utang agregat|Utang perusahaan Qilian International (QLI)|Utang perusahaan SLRN (acelyrin.com)|TFF Pharmaceuticals, Inc. - Gunggung utang perusahaan